Advertisement
Singapore markets closed

  • Straits Times Index

    3,176.51
    -11.15 (-0.35%)
     

  • Nikkei

    37,068.35
    -1,011.35 (-2.66%)
     

  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     

  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     

  • Bitcoin USD

    64,481.25
    +955.76 (+1.50%)
     

  • CMC Crypto 200

    1,385.98
    +73.35 (+5.92%)
     

  • S&P 500

    4,987.83
    -23.29 (-0.46%)
     

  • Dow

    37,933.31
    +157.93 (+0.42%)
     

  • Nasdaq

    15,409.15
    -192.35 (-1.23%)
     

  • Gold

    2,407.60
    +9.60 (+0.40%)
     

  • Crude Oil

    82.94
    +0.21 (+0.25%)
     

  • 10-Yr Bond

    4.6060
    -0.0410 (-0.88%)
     

  • FTSE Bursa Malaysia

    1,547.57
    +2.81 (+0.18%)
     

  • Jakarta Composite Index

    7,087.32
    -79.50 (-1.11%)
     

  • PSE Index

    6,443.00
    -80.19 (-1.23%)
     

Allergan: 3Q Earnings Snapshot

Associated Press
Updated

DUBLIN (AP) _ Allergan PLC (AGN) on Tuesday reported a loss of $786.8 million in its third quarter.

The Dublin-based company said it had a loss of $2.40 per share. Earnings, adjusted for one-time gains and costs, were $4.25 per share.

The results matched Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was also for earnings of $4.25 per share.

The Botox maker posted revenue of $4.05 billion in the period, surpassing Street forecasts. Six analysts surveyed by Zacks expected $3.89 billion.

Allergan expects full-year revenue in the range of $15.63 billion to $15.83 billion.

ADVERTISEMENT

Allergan shares have increased 34% since the beginning of the year, while the Standard & Poor's 500 index has risen 23%. The stock has climbed nearly 10% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AGN at https://www.zacks.com/ap/AGN